Literature DB >> 21189125

A closer look at the high affinity benzodiazepine binding site on GABAA receptors.

Erwin Sigel1, Benjamin P Lüscher.   

Abstract

Ligands of the benzodiazepine binding site of the GABA(A) receptor come in three flavors: positive allosteric modulators, negative allosteric modulators and antagonists all of which can bind with high affinity. The GABA(A) receptor is a pentameric protein which forms a chloride selective ion channel and ligands of the benzodiazepine binding site stabilize three different conformations of this protein. Classical benzodiazepines exert a positive allosteric effect by increasing the apparent affinity of channel opening by the agonist γ-aminobutyric acid (GABA). We concentrate here on the major adult isoform, the α(1)β(2)γ(2) GABA(A) receptor. The classical binding pocket for benzodiazepines is located in a subunit cleft between α(1) and γ(2) subunits in a position homologous to the agonist binding site for GABA that is located between β(2) and α(1) subunits. We review here approaches to this picture. In particular, point mutations were performed in combination with subsequent analysis of the expressed mutant proteins using either electrophysiological techniques or radioactive ligand binding assays. The predictive power of these methods is assessed by comparing the results with the predictions that can be made on the basis of the recently published crystal structure of the acetylcholine binding protein that shows homology to the N-terminal, extracellular domain of the GABA(A) receptor. In addition, we review an approach to the question of how the benzodiazepine ligands are positioned in their binding pocket. We also discuss a newly postulated modulatory site for benzodiazepines at the α(1)/β(2) subunit interface, homologous to the classical benzodiazepine binding pocket.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21189125     DOI: 10.2174/156802611794863562

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  26 in total

Review 1.  Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety.

Authors:  Xia Chen; Joop van Gerven; Adam Cohen; Gabriel Jacobs
Journal:  Acta Pharmacol Sin       Date:  2018-12-05       Impact factor: 6.150

Review 2.  A novel GABA(A) receptor pharmacology: drugs interacting with the α(+) β(-) interface.

Authors:  Werner Sieghart; Joachim Ramerstorfer; Isabella Sarto-Jackson; Zdravko Varagic; Margot Ernst
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Behavioral characterization of knockin mice with mutations M287L and Q266I in the glycine receptor α1 subunit.

Authors:  Yuri A Blednov; Jill M Benavidez; Gregg E Homanics; R Adron Harris
Journal:  J Pharmacol Exp Ther       Date:  2011-10-28       Impact factor: 4.030

Review 4.  Structure, function, and modulation of GABA(A) receptors.

Authors:  Erwin Sigel; Michael E Steinmann
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

Review 5.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

Review 6.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

7.  Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.

Authors:  Simone Mazzaferro; Isabel Bermudez; Steven M Sine
Journal:  Cell Mol Life Sci       Date:  2019-01-01       Impact factor: 9.261

8.  Pentameric ligand-gated ion channel ELIC is activated by GABA and modulated by benzodiazepines.

Authors:  Radovan Spurny; Joachim Ramerstorfer; Kerry Price; Marijke Brams; Margot Ernst; Hugues Nury; Mark Verheij; Pierre Legrand; Daniel Bertrand; Sonia Bertrand; Dennis A Dougherty; Iwan J P de Esch; Pierre-Jean Corringer; Werner Sieghart; Sarah C R Lummis; Chris Ulens
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

9.  Azo-propofols: photochromic potentiators of GABA(A) receptors.

Authors:  Marco Stein; Simon J Middendorp; Valentina Carta; Ervin Pejo; Douglas E Raines; Stuart A Forman; Erwin Sigel; Dirk Trauner
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-11       Impact factor: 15.336

10.  Flumazenil decreases surface expression of α4β2δ GABAA receptors by increasing the rate of receptor internalization.

Authors:  Aarti Kuver; Sheryl S Smith
Journal:  Brain Res Bull       Date:  2015-11-22       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.